UPDATE: Morgan Stanley Downgrades Solazyme On Lack Of Conviction In Long-Term Outcome

By: via Benzinga
In a report published Monday, Morgan Stanley analyst Timothy Radcliff downgraded the rating on Solazyme Inc (NASDAQ: SZYM) from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.